Open Nav

Rain Therapeutics

  • Avanish Vellanki , Rain Therapeutics

Raise investor awareness

  • Date:Thursday, October 18
  • Time:9:15 AM - 9:30 AM
  • Room:Elizabethan D
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Privately Funded Company
  • Company Description/Mission Statement:Rain Therapeutics Inc., a privately-held, clinical stage biotechnology company focused on biomarker-driven, small molecule therapeutics for patients with cancer.
  • Company Website:
  • Company HQ City:Fremont
  • Company HQ Country:United States
  • Company HQ State:California                  
  • CEO/Top Company Official:Avanish Vellanki
  • Main Therapeutic Focus:Oncology
  • Lead Product in Development : Tarloxotinib
  • Development Phase of Primary Product:Phase II
  • Total Amount Raised to Date, In All Rounds:19.4 Million
Avanish Vellanki
Rain Therapeutics